Cutaneous Plasmacytosis with Perineural Involvement
Importance. Cutaneous and systemic plasmacytosis are rare conditions of unknown etiology with characteristic red-brown skin lesions and a mature polyclonal plasma cell infiltrate within the dermis. Perineural plasma cell infiltrates may be a histologic clue to the diagnosis of cutaneous plasmacytosi...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | Case Reports in Dermatological Medicine |
Online Access: | http://dx.doi.org/10.1155/2014/840845 |
id |
doaj-432e724ad85442968247b6ecf4a3e6a2 |
---|---|
record_format |
Article |
spelling |
doaj-432e724ad85442968247b6ecf4a3e6a22020-11-24T22:49:13ZengHindawi LimitedCase Reports in Dermatological Medicine2090-64632090-64712014-01-01201410.1155/2014/840845840845Cutaneous Plasmacytosis with Perineural InvolvementElizabeth A. Brezinski0Maxwell A. Fung1Nasim Fazel2Department of Dermatology, Davis Health System, University of California, 3301 C Street, Suite 1400, Sacramento, CA 95816, USADepartment of Dermatology, Davis Health System, University of California, 3301 C Street, Suite 1400, Sacramento, CA 95816, USADepartment of Dermatology, Davis Health System, University of California, 3301 C Street, Suite 1400, Sacramento, CA 95816, USAImportance. Cutaneous and systemic plasmacytosis are rare conditions of unknown etiology with characteristic red-brown skin lesions and a mature polyclonal plasma cell infiltrate within the dermis. Perineural plasma cell infiltrates may be a histologic clue to the diagnosis of cutaneous plasmacytosis. Observations. Our patient had a five-year history of persistent reddish-brown plaques on the neck and trunk without systemic symptoms. Histologic examination showed dermal perivascular and perineural plasma cells with excess lambda light chain expression. Due to decreased quality of life caused by his skin lesions, he was placed on a chemotherapeutic regimen with bortezomib. Conclusions and Relevance. The patient was diagnosed with cutaneous plasmacytosis based on classic histopathology results with a recently characterized pattern of perineural involvement. Bortezomib therapy was initiated to manage his skin eruption, which has not been previously described as a treatment for this chronic condition.http://dx.doi.org/10.1155/2014/840845 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Elizabeth A. Brezinski Maxwell A. Fung Nasim Fazel |
spellingShingle |
Elizabeth A. Brezinski Maxwell A. Fung Nasim Fazel Cutaneous Plasmacytosis with Perineural Involvement Case Reports in Dermatological Medicine |
author_facet |
Elizabeth A. Brezinski Maxwell A. Fung Nasim Fazel |
author_sort |
Elizabeth A. Brezinski |
title |
Cutaneous Plasmacytosis with Perineural Involvement |
title_short |
Cutaneous Plasmacytosis with Perineural Involvement |
title_full |
Cutaneous Plasmacytosis with Perineural Involvement |
title_fullStr |
Cutaneous Plasmacytosis with Perineural Involvement |
title_full_unstemmed |
Cutaneous Plasmacytosis with Perineural Involvement |
title_sort |
cutaneous plasmacytosis with perineural involvement |
publisher |
Hindawi Limited |
series |
Case Reports in Dermatological Medicine |
issn |
2090-6463 2090-6471 |
publishDate |
2014-01-01 |
description |
Importance. Cutaneous and systemic plasmacytosis are rare conditions of unknown etiology with characteristic red-brown skin lesions and a mature polyclonal plasma cell infiltrate within the dermis. Perineural plasma cell infiltrates may be a histologic clue to the diagnosis of cutaneous plasmacytosis. Observations. Our patient had a five-year history of persistent reddish-brown plaques on the neck and trunk without systemic symptoms. Histologic examination showed dermal perivascular and perineural plasma cells with excess lambda light chain expression. Due to decreased quality of life caused by his skin lesions, he was placed on a chemotherapeutic regimen with bortezomib. Conclusions and Relevance. The patient was diagnosed with cutaneous plasmacytosis based on classic histopathology results with a recently characterized pattern of perineural involvement. Bortezomib therapy was initiated to manage his skin eruption, which has not been previously described as a treatment for this chronic condition. |
url |
http://dx.doi.org/10.1155/2014/840845 |
work_keys_str_mv |
AT elizabethabrezinski cutaneousplasmacytosiswithperineuralinvolvement AT maxwellafung cutaneousplasmacytosiswithperineuralinvolvement AT nasimfazel cutaneousplasmacytosiswithperineuralinvolvement |
_version_ |
1725676753092870144 |